Published in Int J Nephrol on November 03, 2016
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med (2008) 9.87
Acute renal failure and sepsis. N Engl J Med (2004) 7.18
Polyomavirus BK. Lancet Infect Dis (2003) 2.99
Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med (1993) 2.91
Once-daily aminoglycoside dosing: An update on current literature. Am J Health Syst Pharm (2015) 2.63
Venoocclusive disease of the liver following bone marrow transplantation. Transplantation (1987) 2.35
Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: results of a prospective, randomized, controlled study in critically ill patients. Crit Care Med (1996) 2.20
Crystal-induced acute renal failure. Am J Med (1999) 2.12
A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis (1997) 1.90
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplant (2009) 1.87
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion (2004) 1.84
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood (2008) 1.71
The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood (1995) 1.61
Renal failure associated with cancer and its treatment: an update. J Am Soc Nephrol (2004) 1.58
Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity. Crit Care Med (2004) 1.48
BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results. Am J Transplant (2010) 1.43
Studies of mechanisms and protective maneuvers in myoglobinuric acute renal injury. Lab Invest (1989) 1.38
Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors. Kidney Int (2005) 1.35
Acyclovir-induced renal failure. Clinical course and histology. Am J Med (1988) 1.33
Renal function after acyclovir intravenous injection. Am J Med (1982) 1.28
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood (2016) 1.27
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant (2015) 1.22
Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology (2003) 1.21
A novel role for uric acid in acute kidney injury associated with tumour lysis syndrome. Nephrol Dial Transplant (2009) 1.21
An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome. Cancer Treat Rev (2009) 1.17
Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis. Clin J Am Soc Nephrol (2009) 1.15
Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant (2008) 1.11
Acute renal failure in the setting of bone marrow transplantation. Kidney Int (1994) 1.10
Empirical antifungal therapy--new options, new tradeoffs. N Engl J Med (2002) 1.08
Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation. Blood (1997) 1.07
Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2013) 1.07
Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Leukemia (2011) 1.07
Onco-nephrology: AKI in the cancer patient. Clin J Am Soc Nephrol (2012) 1.02
Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol (2006) 1.02
Adenovirus nephritis in hematopoietic stem-cell transplantation. Transplantation (2004) 0.98
The influence of mannitol on myoglobinuric acute renal failure: functional, biochemical, and morphological assessments. J Am Soc Nephrol (1991) 0.98
A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT. Bone Marrow Transplant (2010) 0.97
Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation. Chin J Cancer (2010) 0.97
Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients. J Antimicrob Chemother (2002) 0.96
Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation. Bone Marrow Transplant (2006) 0.94
Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival. Bone Marrow Transplant (2008) 0.93
Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation. Bone Marrow Transplant (2006) 0.93
The kidney effects of hematopoietic stem cell transplantation. Adv Chronic Kidney Dis (2014) 0.93
Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol (2010) 0.92
Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood (1989) 0.92
Renal function in high dose chemotherapy and autologous hematopoietic cell support treatment for breast cancer. Kidney Int (1996) 0.91
Necrotizing tubulointerstitial nephritis associated with adenovirus infection. Hum Pathol (1991) 0.90
Frequency, risk factors, and outcome of acute kidney injury following bone marrow transplantation at Dr Shariati Hospital in Tehran. Iran J Kidney Dis (2010) 0.89
Acute renal failure following myeloablative autologous and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2006) 0.87
Acute kidney injury following HCT: incidence, risk factors and outcome. Bone Marrow Transplant (2011) 0.87
Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome. Am J Nephrol (1995) 0.86
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience. Biol Blood Marrow Transplant (2009) 0.86
Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients. Transplantation (2005) 0.86
Acute renal failure after nonmyeloablative hematopoietic cell transplantation. J Am Soc Nephrol (2004) 0.85
Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.85
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. Transplantation (2016) 0.85
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease. Ther Adv Hematol (2012) 0.84
Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2014) 0.83
Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy. Am J Transplant (2006) 0.82
Acute renal failure associated with autologous bone marrow transplantation. Bone Marrow Transplant (1987) 0.81
Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis (2004) 0.80
Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria. Intern Med (2012) 0.80
Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation. Ann Transplant (2013) 0.80
Inhibition of insulin release by cyclosporine and production of peripheral insulin resistance in the dog. Transplantation (1990) 0.79
Role of Urine Neutrophil Gelatinase-Associated Lipocalin in the Early Diagnosis of Amphotericin B-Induced Acute Kidney Injury. Antimicrob Agents Chemother (2015) 0.79
Hematuria due to adenoviral infection in bone marrow transplant recipients. Transplant Proc (2010) 0.79
Evaluation of the effects of preconditioning regimens on hepatic veno-occlusive disease in mice after hematopoietic stem cell transplantation. Exp Mol Pathol (2014) 0.79
[Early identification of acute kidney injury after hematopoietic stem cell transplantation by the measurement of urinary biomarkers]. Nihon Jinzo Gakkai Shi (2011) 0.78
Renal comorbidity after solid organ and stem cell transplantation. Am J Transplant (2012) 0.78
A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT. Bone Marrow Transplant (2009) 0.78
Urinary elafin and kidney injury in hematopoietic cell transplant recipients. Clin J Am Soc Nephrol (2014) 0.77
Cyclosporine-associated thrombotic microangiopathy and thrombocytopenia-associated multiple organ failure: a case successfully treated with therapeutic plasma exchange. J Pediatr Hematol Oncol (2014) 0.77
Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature. Transpl Int (2015) 0.76
Concentrated ascites reinfusion therapy for sinusoidal obstructive syndrome after hematopoietic stem cell transplantation. Artif Organs (2013) 0.76
Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA? Bone Marrow Transplant (2013) 0.76
Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis. Exp Clin Transplant (2013) 0.76
[Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation]. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2009) 0.76
A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation. Hematol Oncol (2014) 0.76
A case of thrombotic micro-angiopathy after heart transplantation successfully treated with eculizumab. Transpl Int (2015) 0.76
Successful treatment with intravesical cidofovir for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: A case report and a review of the literature. J Infect Chemother (2016) 0.76
Measurement of circulating endothelial cells to support the diagnosis of veno-occlusive disease after hematopoietic stem cell transplantation. Int J Lab Hematol (2013) 0.75
Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience. Clin Nephrol (2012) 0.75